Last reviewed · How we verify

NCT01960582: FORMASEvid

Evaluation of Housing Adaptations and Mobility Devices

Completed NA Last updated 9 October 2020
What this trial tests

NA trial testing New Practice Strategy in Activities of Daily Living in 340 participants. Completed in 30 April 2020.

Timeline
11 January 2013
Primary endpoint
30 April 2020
30 April 2020

Quick facts

Lead sponsorLund University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment340
Start date11 January 2013
Primary completion30 April 2020
Estimated completion30 April 2020
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Lund University

Who can join

20 and older, any sex, with Activities of Daily Living or Cost Effectiveness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The rationale underlying this project is the fact that HA is a very common compensatory interven¬tion within municipality health care, undertaken to support an independent living in the own home. In addition, MD are frequently prescribed and used among HA clients in order to compensate for declined body functions. In spite of this, knowledge of their effects for the individual and the society is still scarce. In particular, systematic, evidence-based strategies based on clear-cut conceptual definitions and descriptions of procedures are lacking. Such strategies are crucial in order to evaluate the effects of HA and MD. In addition, longterm cost-effectiveness evaluations are crucial for policy implementation. The overarching aim is to investigate outcomes of HA on aspects of home and health for sub-groups of persons with disabilities. The specific aims are to: * Investigate the effects of HA on home and health related outcomes, i.e. usability, fear of falling, activity/participation and health-related quality of life for different subgroups of persons, e.g. MD users and non MD-users * Investigate the use of a new practice strategy for HA on home and health related outcomes for subgroups of persons with disabilities in terms of differences between municipalities * Investigate societal level outcomes of HA and MD, i.e. costs and quality adjusted life years * Gain a deeper understanding of the processes behind changes in outcomes We hypothesise that using a structure strategy for housing adaptation and mobility devices case management in ordinary practice in Swedish municipalities increase activity, participation, the usability of the home, and reduces societal costs.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Health-Related Quality of Life among People Applying for Housing Adaptations: Associated Factors.
    Boström L, Chiatti C, Thordardottir B, Ekstam L, et al · · 2018 · cited 11× · PMID 30262784 · DOI 10.3390/ijerph15102130
  2. Falls and Fear of Falling among Persons Who Receive Housing Adaptations-Results from a Quasi-Experimental Study in Sweden.
    Carlsson G, Nilsson MH, Ekstam L, Chiatti C, et al · · 2017 · cited 9× · PMID 28961158 · DOI 10.3390/healthcare5040066
  3. A research-based strategy for managing housing adaptations: study protocol for a quasi-experimental trial.
    Ekstam L, Carlsson G, Chiatti C, Nilsson MH, et al · · 2014 · cited 8× · PMID 25432718 · DOI 10.1186/s12913-014-0602-5
  4. Effects of applying a standardized assessment and evaluation protocol in housing adaptation implementation - results from a quasi-experimental study.
    Malmgren Fänge A, Carlsson G, Axmon A, Thordardottir B, et al · · 2019 · cited 2× · PMID 31684916 · DOI 10.1186/s12889-019-7815-9

Verify or expand the search:

Other recruiting trials for Activities of Daily Living

Currently open trials in the same condition.

Other Lund University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01960582.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing